Clinical Results and Testimonials

Japan IMMUNisBIO Center

Total cancer patients used MYJ1633 in 2019:

0

Korea IMMUNisBIO Center

Recurrence-free
Survival Rate
Improved 8.13 Times

• Enrollment: 18 patients with end-stage cancer
• Intervention: 10 sessions of MYJ1633
• Result: All patients are alive (up to March 2021)
• The longest survival period: 27 months

Case Study – Pancreatic cancer

Patient 1
Pancreatic cancer with liver metastasis, Stage IV F/63
MYJ1633 ‒ 5 sessions

Before treatment
Symptoms: general weakness, low appetite, abdominal pain, nausea
Concurrent treatment: Chemotherapy, cyber knife

After treatment
Symptoms: all resolved ‒ no pain, gain appetite
Tumor size both primary and metastatic decreased remarkably

Case Study – Lung cancer

Patient 2
Lung cancer with lymph node metastasis, Stage IV M/65
MYJ1633 ‒ 7 sessions

Before treatment
Symptoms: persistent cough, general weakness, low appetite, pain, nausea
Concurrent treatment: Radiotherapy, chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no cough
Tumor size decreased from 6 cm to 2 cm

Case Study – Malignant lymphoma

Patient 3
Malignant lymphoma with lung metastasis, Stage IV M/60
MYJ1633 ‒ 4 sessions

Before treatment
Symptoms: persistent infection, general weakness, low appetite, pain
Concurrent treatment: Chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no general weakness, less infection
Tumor size decreased from 6 cm to 2.5 cm

Cancer

Japan IMMUNisBIO Center

Total cancer patients used MYJ1633 in 2019:

0

Korea IMMUNisBIO Center

Recurrence-free
Survival Rate
Improved 8.13 Times

• Enrollment: 18 patients with end-stage cancer
• Intervention: 10 sessions of MYJ1633
• Result: All patients are alive (up to March 2021)
• The longest survival period: 27 months

Case Study – Pancreatic cancer

Patient 1
Pancreatic cancer with liver metastasis, Stage IV F/63
MYJ1633 ‒ 5 sessions

Before treatment
Symptoms: general weakness, low appetite, abdominal pain, nausea
Concurrent treatment: Chemotherapy, cyber knife

After treatment
Symptoms: all resolved ‒ no pain, gain appetite
Tumor size both primary and metastatic decreased remarkably

Case Study – Lung cancer

Patient 2
Lung cancer with lymph node metastasis, Stage IV M/65
MYJ1633 ‒ 7 sessions

Before treatment
Symptoms: persistent cough, general weakness, low appetite, pain, nausea
Concurrent treatment: Radiotherapy, chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no cough
Tumor size decreased from 6 cm to 2 cm

Case Study – Malignant lymphoma

Patient 3
Malignant lymphoma with lung metastasis, Stage IV M/60
MYJ1633 ‒ 4 sessions

Before treatment
Symptoms: persistent infection, general weakness, low appetite, pain
Concurrent treatment: Chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no general weakness, less infection
Tumor size decreased from 6 cm to 2.5 cm

Japan IMMUNisBIO Center

Total cancer patients used MYJ1633 in 2019:

0

Korea IMMUNisBIO Center

Recurrence-free
Survival Rate
Improved 8.13 Times

• Enrollment: 18 patients with end-stage cancer
• Intervention: 10 sessions of MYJ1633
• Result: All patients are alive (up to March 2021)
• The longest survival period: 27 months

Case Study – Pancreatic cancer

Patient 1
Pancreatic cancer with liver metastasis, Stage IV F/63
MYJ1633 ‒ 5 sessions

Before treatment
Symptoms: general weakness, low appetite, abdominal pain, nausea
Concurrent treatment: Chemotherapy, cyber knife

After treatment
Symptoms: all resolved ‒ no pain, gain appetite
Tumor size both primary and metastatic decreased remarkably

Case Study – Lung cancer

Patient 2
Lung cancer with lymph node metastasis, Stage IV M/65
MYJ1633 ‒ 7 sessions

Before treatment
Symptoms: persistent cough, general weakness, low appetite, pain, nausea
Concurrent treatment: Radiotherapy, chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no cough
Tumor size decreased from 6 cm to 2 cm

Case Study – Malignant lymphoma

Patient 3
Malignant lymphoma with lung metastasis, Stage IV M/60
MYJ1633 ‒ 4 sessions

Before treatment
Symptoms: persistent infection, general weakness, low appetite, pain
Concurrent treatment: Chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no general weakness, less infection
Tumor size decreased from 6 cm to 2.5 cm

Autoimmune disease is characterised by your immune system mistakenly attacks your own normal healthy cells.

The most common autoimmune disease are:
• Rheumatoid arthritis
• Thyroid autoimmune diseases Graves’ disease, Hashimoto’s thyroiditis
• Psoriasis
• Systemic lupus erythematosus (SLE)

Find us for more information on how NK cell therapy works in autoimmune disease.

Aging is a natural irreversible process that impairs skin, muscle, vital organs as well as our body immune system. This leads to gradual decline in physical and mental ability.

As aging process is unstoppable, you can maintain an active life by boosting your own immune system. NK cell therapy is able to benefit you by removing aged and abnormal cells in your body, in order to slow the process of aging.

Find us for more information on how NK cell therapy helps to combat the effects of natural aging process.

Cancer

Japan IMMUNisBIO Center

Total cancer patients used MYJ1633 in 2019:

0

Korea IMMUNisBIO Center

Recurrence-free
Survival Rate
Improved 8.13 Times

• Enrollment: 18 patients with end-stage cancer
• Intervention: 10 sessions of MYJ1633
• Result: All patients are alive (up to March 2021)
• The longest survival period: 27 months

Case Study – Pancreatic cancer

Patient 1
Pancreatic cancer with liver metastasis, Stage IV F/63
MYJ1633 ‒ 5 sessions

Before treatment
Symptoms: general weakness, low appetite, abdominal pain, nausea
Concurrent treatment: Chemotherapy, cyber knife

After treatment
Symptoms: all resolved ‒ no pain, gain appetite
Tumor size both primary and metastatic decreased remarkably

Case Study – Lung cancer

Patient 2
Lung cancer with lymph node metastasis, Stage IV M/65
MYJ1633 ‒ 7 sessions

Before treatment
Symptoms: persistent cough, general weakness, low appetite, pain, nausea
Concurrent treatment: Radiotherapy, chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no cough
Tumor size decreased from 6 cm to 2 cm

Case Study – Malignant lymphoma

Patient 3
Malignant lymphoma with lung metastasis, Stage IV M/60
MYJ1633 ‒ 4 sessions

Before treatment
Symptoms: persistent infection, general weakness, low appetite, pain
Concurrent treatment: Chemotherapy

After treatment
Symptoms: all resolved ‒ no pain, gain appetite, no general weakness, less infection
Tumor size decreased from 6 cm to 2.5 cm

Autoimmune Disease

Autoimmune disease is characterised by your immune system mistakenly attacks your own normal healthy cells.

The most common autoimmune disease are:
• Rheumatoid arthritis
• Thyroid autoimmune diseases Graves’ disease, Hashimoto’s thyroiditis
• Psoriasis
• Systemic lupus erythematosus (SLE)

Find us for more information on how NK cell therapy works in autoimmune disease.

Anti-aging

Aging is a natural irreversible process that impairs skin, muscle, vital organs as well as our body immune system. This leads to gradual decline in physical and mental ability.

As aging process is unstoppable, you can maintain an active life by boosting your own immune system. NK cell therapy is able to benefit you by removing aged and abnormal cells in your body, in order to slow the process of aging.

Find us for more information on how NK cell therapy helps to combat the effects of natural aging process.